Past Events › Conference
Events Search and Views Navigation
There is still significant human variability in metabolite identification for targets and pathways. These challenges affect the advancement in biomarker development, mass spectrometry-cased imaging, big data, and the application of metabolomics for drug discovery and development. Join us for an event that presents new research and offers networking opportunities with the researchers and scientists who are working on developing clinical assays, connecting the metabolome and the genome, and establishing common quality standards for experimental data.Find out more »
The International Neuromodulation Society promotes improvement in patient health care by providing physicians and allied health care professionals with high quality, evidence-based educational activities focusing on advances in the field of neuromodulation; basic, translational and clinical research; new technology; and global health care. The overarching goals are to enhance learners’ knowledge, competence and performance to improve patient access, selection, safety and clinical outcomes.Find out more »
With the theme of “Drug Discovery to Health Outcomes: Population to Patient”, the 2016 Canadian Society for Pharmaceutical Sciences Conference will begin the conference with Industry Day, highlighting the latest trends in drug discovery and development within big pharma and the start-up biotech industry. Speakers from GSK, J&J, Pfizer, Janssen, BIOTECanada, and Vancouver area biotechnology companies will address new trends in R&D, innovative therapies, drug delivery, commercialization, big data and regulatory issues, concluding with a view to the future. Following industry day, the CSPS conference continues with 11 sessions featuring national and international speakers on a variety of topics including drug targeting, special populations, pharmacogenomics, regulatory updates, health sustainability, and formulary challenges. Drug delivery sessions include nanomedicines, responsive drug delivery, and protein/peptide delivery systems and are complemented by a session on analytical innovation to support precision medicine and biologics development.Find out more »
The aim of the congress is to offer a unique opportunity for sharing selected aspects on the latest evidence-based research findings and applications. Also, the congress is a stimulating forum for professional development and establishing fruitful global and regional collaboration. Newly integrated into the congress program are the academic, scientific, and corporate project development day, the exchange and career fair for students, the industry training center, and new innovative congress technologies for delegates. More than 80 invited speakers will attend the congress and we expect more than 2000 participants. Our hope is that many young scientists, especially PhD. students and postdoctoral fellows, will attend and share their perspectives. After all, the younger generation represents the promise of the field. The congress theme, “Exploring cellular structure and function” recognises the key role that cell biology plays in the management of deeper understanding of the tissues and organisms that cells compose. We have done the utmost to create a program in line with the theme.Find out more »
The American Physiological Society (APS) and The Physiological Society (TPS) are delighted to announce that the “Physiology” meeting will be co-hosted in the Convention Centre Dublin from July 29–31, 2016. This partnership between the two oldest and largest physiological societies in the world marks the 140th anniversary of the founding of TPS and the 129th of the APS and is a continuation of a program of strategic collaborations. TPS President, Professor Richard Vaughan-Jones said, “I am truly delighted that this international meeting re-affirms the close collaboration between The Physiological Society and the American Physiological Society. It builds on the strategic links forged by our joint founding, in 2013, of the online scientific journal, Physiological Reports. The meeting in Dublin will permit us to demonstrate publicly the role of physiology as a major scientific discipline in the post-genomic world.” APS President David M. Pollock commented, “Physiology gives relevance to all other scientific disciplines, and like all discovery, knows no boundaries.” The meeting will be comprised of oral and poster communications, symposia, keynote and plenary lectures, interspersed by general interest workshops and networking opportunities. The meeting will be preceded by an Early Career Physiologists Symposium on July 28th. Dublin and the surrounding area offer a host of exciting extracurricular activities for those wishing to extend their stay.Find out more »
GTCbio’s Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed. Come join us to learn what categories of companies are currently commercially viable, how they’re being funded, and what kind of strategic relationships are available within the industry!Find out more »
Abstract Deadline: March 22, 2017
Registration Deadline: May 3, 2017
This symposium will focus on the molecular basis of major neurodegenerative diseases such as Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis, with a strong emphasis on mechanism based drug development. The meeting will cover the various molecular mechanisms linked to these diseases, including RNA biology, nuclear transport, protein processing, protein aggregation and protein folding. The symposium will also address the genetic components underlying neurodegeneration and the involvement of innate immune responses, discuss disease biomarkers and therapeutic options, as well as using animal models for studying neurodegenerative disease. The aim of the meeting is to promote discussions and sharing of new findings among basic scientists, clinical researchers, and their counterparts from pharmaceutical industry, in order to advance our understanding of neurodegeneration and to further drug development in an area urgently requiring therapeutic progress.Find out more »
Renowned for creating chemistry through ideas, people and scientific theories, SEB’s Annual Meeting will challenge your mind and increase your connections. Network with around 800 colleagues from across the globe and choose from a whole host of stimulating sessions. Listen and debate with world-class experimental biologists and take part in the exciting social events that will be on offer.Find out more »
Jointly with the International Advisory Committee, we are putting an exciting programme that will span all aspects of oxytocin and vasopressin research from cellular physiology to behaviour. The most recent advances in the field will be presented by leading researchers. There will also be ample opportunity for new and emerging researchers to present their work as part of symposiums, oral presentation programme or at the poster session.
At this time, we invite you to submit proposals for Symposia at WCNH 2017. All proposals must be submitted through the e-mail firstname.lastname@example.org from now up to 31 October 2016. The proposals should follow this template form. The submitted symposia proposals will be evaluated by the Local Organizing and the International Advisory Committees, and the selected ones will be announced by 15 November 2016.Find out more »
In the last two decades it has become apparent that mitochondria perform a multitude of functions to maintain cellular homeostasis, all of which are intimately linked to bioenergetics. New cutting edge technology, novel molecular tools and mitochondrially targeted therapeutics developed in the past five years have made it possible to more accurately and deeply probe mitochondrial function and have dramatically altered the study of bioenergetics under physiological conditions.
Our knowledge of the mechanisms by which mitochondrial function is regulated and its contribution to cellular homeostasis is also rapidly expanding. However, these advances are generally made in the context of a specific pathology or organ system and are not always widely recognized by investigators studying a different pathology. Further, a great gap in knowledge still exists in translating mitochondrial measurement to human studies.
The goal of the “Physiological Bioenergetics- from Bench to Bedside” conference is to bring together experts studying varied facets of bioenergetics across disciplines and in the context of different pathologies to share their most recent findings and to discuss strategies to advance the field of “mitochondriology” into translational and clinical studies. This is a “”must attend”” conference for a researcher at any stage of their career who is interested in studying mitochondrial function or integrated bioenergetics.Find out more »
You can participate in very active discussions and cutting‐edge lectures by the world’s top scientists and neurologists including three Nobel laureates as well as hear all the advances of scientific and clinical neurology. Gene therapy and stem/ iPS cell medicine are such examples on the one hand and Brain‐Machine‐Interface, information technology and robotics in care and rehabilitation on the other. Neurology related to environmental and disaster medicine will also attract many neurologists particularly in rapidly developing counties.Find out more »
GTCbio is proud to present the Stem Cell Summit 2018, to be held in Boston, MA. The Stem Cell Summit provides information on cutting-edge developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells. This summit comprises of presentations, panels and round-table discussions to highlight pre-clinical and clinical studies in regenerative medicine, immunotherapy, stem cell reprogramming, cell therapy in diabetes, regulatory policies regarding stem cell research, manufacturing and other relevant topics.Find out more »
Experimental Biology (EB) is the annual meeting of five societies bringing together more than 12,000 scientists and 25 guest societies in one interdisciplinary community. EB is the place to explore the latest cutting edge science in anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. EB welcomes everyone with interest in advancing the latest research impacting life sciences. Attendees represent scientists from academic institutions, government agencies, non-profit organizations and industry. This multidisciplinary, scientific meeting features plenary lectures, workshops, symposia, posters presentations, on-site career services, and exhibits spotlighting products and services integral to this professional community.Find out more »